1-[1-(4-氟苯基)-2,5-二甲基-1H-吡咯-3-基]-2-(1-吡咯烷基)乙酮
![1-[1-(4-氟苯基)-2,5-二甲基-1H-吡咯-3-基]-2-(1-吡咯烷基)乙酮结构式](https://image.chemsrc.com/caspic/424/314245-33-5.png)
1-[1-(4-氟苯基)-2,5-二甲基-1H-吡咯-3-基]-2-(1-吡咯烷基)乙酮结构式
|
常用名 | 1-[1-(4-氟苯基)-2,5-二甲基-1H-吡咯-3-基]-2-(1-吡咯烷基)乙酮 | 英文名 | IU1 |
|---|---|---|---|---|
| CAS号 | 314245-33-5 | 分子量 | 300.371 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 437.0±45.0 °C at 760 mmHg | |
| 分子式 | C18H21FN2O | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 218.1±28.7 °C | |
| 符号 |
GHS05 |
信号词 | Danger |
|
Post-endocytotic Deubiquitination and Degradation of the Metabotropic γ-Aminobutyric Acid Receptor by the Ubiquitin-specific Protease 14.
J. Biol. Chem. 291 , 7156-70, (2016) Mechanisms controlling the metabotropic γ-aminobutyric acid receptor (GABAB) cell surface stability are still poorly understood. In contrast with many other G protein-coupled receptors (GPCR), it is not subject to agonist-promoted internalization, but is cons... |
|
|
Ubiquitin-specific protease 14 modulates degradation of cellular prion protein.
Sci. Rep. 5 , 11028, (2015) Prion diseases are fatal neurodegenerative disorders characterized by the accumulation of prion protein (PrP(C)). To date, there is no effective treatment for the disease. The accumulated PrP, termed PrP(Sc), forms amyloid fibrils and could be infectious. It ... |
期刊文献综述：
更多...